| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.403 | 0.098 | 0.403 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.402 0.099 CID_154700139 | ||
| 0.368 | 0.077 | 0.415 | GABA C receptor rho-3 antagonist | 0.415 0.055 CID_154700139 | CID_154700139 | |
| 0.275 | 0.019 | 0.275 | Heat shock protein 90 alpha antagonist | 0.149 0.087 CID_154700139 | ||
| 0.287 | 0.058 | 0.287 | Tumour necrosis factor alpha release inhibitor | 0.263 0.069 CID_154700139 | ||
| 0.268 | 0.044 | 0.268 | Peroxidase inhibitor | |||
| 0.24 | 0.017 | 0.24 | MAP kinase kinase inhibitor | 0.194 0.03 CID_154700139 | ||
| 0.317 | 0.12 | 0.317 | MAP kinase kinase 6 inhibitor | 0.252 0.188 CID_154700139 | ||
| 0.234 | 0.05 | 0.234 | MAP kinase kinase 3 inhibitor | 0.218 0.078 CID_154700139 | ||
| 0.21 | 0.028 | 0.21 | Death-associated protein kinase 2 inhibitor | |||
| 0.202 | 0.037 | 0.202 | Heat shock protein 90 antagonist | |||
| 0.237 | 0.084 | 0.237 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.212 0.133 CID_154700139 | ||
| 0.165 | 0.048 | 0.165 | MAP kinase 3 inhibitor | |||
| 0.142 | 0.052 | 0.142 | Death-associated protein kinase 1 inhibitor | |||
| 0.111 | 0.023 | 0.111 | Dopamine agonist | |||
| 0.094 | 0.013 | 0.094 | AMPA receptor antagonist | |||
| 0.216 | 0.139 | 0.216 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.181 | 0.104 | 0.181 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.14 | 0.065 | 0.14 | Phosphodiesterase inhibitor | |||
| 0.102 | 0.03 | 0.102 | Phosphodiesterase 11A inhibitor | 0.084 0.052 CID_154700139 | ||
| 0.102 | 0.03 | 0.102 | Phosphodiesterase XI inhibitor | 0.084 0.052 CID_154700139 | ||
| 0.098 | 0.043 | 0.098 | Bromodomain-containing protein 2 inhibitor | 0.09 0.056 CID_154700139 | ||
| 0.161 | 0.106 | 0.257 | Pyruvate kinase inhibitor | 0.257 0.059 CID_154700139 | CID_154700139 | |
| 0.064 | 0.01 | 0.064 | Histone deacetylase class II inhibitor | |||
| 0.077 | 0.025 | 0.077 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.078 | 0.033 | 0.078 | Histone deacetylase inhibitor | |||
| 0.054 | 0.01 | 0.054 | Histone deacetylase class IIb inhibitor | |||
| 0.137 | 0.093 | 0.151 | GABA C receptor rho-2 antagonist | 0.151 0.072 CID_154700139 | CID_154700139 | |
| 0.053 | 0.01 | 0.053 | Histone deacetylase 6 inhibitor | |||
| 0.121 | 0.079 | 0.167 | Cyclooxygenase 1 inhibitor | 0.167 0.049 CID_154700139 | CID_154700139 | |
| 0.06 | 0.021 | 0.06 | Phosphodiesterase X inhibitor | |||
| 0.06 | 0.021 | 0.06 | Phosphodiesterase 10A inhibitor | |||
| 0.076 | 0.038 | 0.076 | MAP kinase kinase 8 inhibitor | |||
| 0.05 | 0.016 | 0.05 | Histone deacetylase 5 inhibitor | |||
| 0.075 | 0.042 | 0.075 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.036 | 0.006 | 0.036 | Dopamine D1 agonist | 0.03 0.009 CID_154700139 | ||
| 0.108 | 0.08 | 0.108 | Alkylator | |||
| 0.041 | 0.013 | 0.041 | Histone deacetylase 1 inhibitor | |||
| 0.101 | 0.076 | 0.101 | GABA C receptor antagonist | |||
| 0.151 | 0.13 | 0.151 | Focal adhesion kinase 2 inhibitor | 0.145 0.139 CID_154700139 | ||
| 0.107 | 0.087 | 0.107 | Transcription factor STAT6 inhibitor | |||
| 0.06 | 0.041 | 0.06 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.038 | 0.018 | 0.038 | Histone deacetylase class IIa inhibitor | |||
| 0.036 | 0.021 | 0.036 | Histone deacetylase 2 inhibitor | |||
| 0.071 | 0.058 | 0.071 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.034 | 0.023 | 0.034 | ADAM10 endopeptidase inhibitor | |||
| 0.033 | 0.023 | 0.033 | Protein kinase C beta I inhibitor | |||
| 0.03 | 0.023 | 0.03 | Histone deacetylase class IV inhibitor | |||
| 0.03 | 0.023 | 0.03 | Histone deacetylase 11 inhibitor | |||
| 0.05 | 0.044 | 0.05 | GABA receptor antagonist | |||
| 0.111 | 0.11 | 0.14 | Cyclooxygenase inhibitor | 0.14 0.079 CID_154700139 | CID_154700139 | |
| 0.012 | 0.01 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.047 | 0.046 | 0.047 | GABA A receptor antagonist | |||
| 0.062 | 0.065 | 0.066 | Porphobilinogen synthase inhibitor | 0.066 0.06 CID_154700139 | CID_154700139 | |
| 0.131 | 0.148 | 0.181 | Non-steroidal antiinflammatory agent | 0.181 0.086 CID_154700139 | CID_154700139 | |
| 0.11 | 0.129 | 0.135 | Insulin secretagoues | 0.135 0.09 CID_154700139 | CID_154700139 | |
| 0.089 | 0.122 | 0.112 | Cyclooxygenase 2 inhibitor | 0.112 0.089 CID_154700139 | CID_154700139 | |
| 0.091 | 0.148 | 0.143 | Interleukin 1 antagonist | 0.143 0.063 CID_154700139 | CID_154700139 | |
| 0.059 | 0.255 | 0.123 | Cholinergic | 0.123 0.104 CID_154700139 | CID_154700139 | |
| 0.16 | 0.396 | 0.411 | Antiinflammatory | 0.411 0.133 CID_154700139 | CID_154700139 | |
| 0.025 | 0.264 | 0.101 | Cyclin-dependent kinase 5 inhibitor | 0.101 0.074 CID_154700139 | CID_154700139 | |
| 0.054 | 0.323 | 0.191 | Aurora-C kinase inhibitor | 0.191 0.022 CID_154700139 | CID_154700139 | |
| 0.021 | 0.332 | 0.219 | Topoisomerase I inhibitor | 0.219 0.022 CID_154700139 | CID_154700139 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |